Read more

October 24, 2021
1 min read
Save

Children’s hospital appoints chief of pediatric hematology-oncology division

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Oren J. Becher, MD, has been appointed chief of the Jack Martin division of pediatric hematology-oncology at Mount Sinai Kravis Children’s Hospital.

Becher also will serve as Steven Ravitch chair in pediatric hematology, as well as professor of pediatrics at Icahn School of Medicine at Mount Sinai.

Becher is recognized for his expertise in pediatric brain tumors. His research over the past decade has focused on identifying therapeutic targets to treat diffuse intrinsic pontine glioma.

Oren J. Becher, MD
Oren J. Becher

“We are thrilled to welcome Dr. Becher to Mount Sinai Kravis Children’s Hospital, where his expertise in pediatric brain cancers — most notably his contribution to our understanding of genetic alterations in [diffuse intrinsic pontine glioma] — will be highly valued among our faculty and the families in our care,” Lisa Satlin, MD, chair of the Jack and Lucy Clark department of pediatrics at Icahn School of Medicine at Mount Sinai, said in a press release.

Becher previously held appointments in the department of pediatrics and the department of biochemistry and molecular genetics at Northwestern University. He also had clinical responsibilities at Ann & Robert H. Lurie Children's Hospital of Chicago.

“It is my honor to join the Mount Sinai family and the outstanding collaborative environment there,” Becher said in the release. “Icahn Mount Sinai’s strengths in neuroscience, genomics and cancer research will provide a fertile ground for the development of innovative clinical trials for children with cancer and hematological diseases.”